articleTop 10% cited

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1

Journal of Immunological Methods · 2013 · Vol. 409 · pp. 131–146

Marcella Sarzotti‐Kelsoe✉(Duke University Hospital)Robert T. Bailer(National Institutes of Health)Esra Abacı Türk(National Institutes of Health)Lin Chenli(National Institutes of Health)Miroslawa Bilska(Duke Medical Center)Kelli Greene(Duke Medical Center)Hongmei Gao(Duke Medical Center)Christopher A. Todd(Duke Medical Center)Daniel A. Ozaki(Duke Medical Center)Michael S. Seaman(Harvard University)John R. Mascola(National Institutes of Health)David C. Montefiori(Duke Medical Center)

View via DOI Publisher page

HIV Research and Treatment Virus-based gene therapy research HIV/AIDS drug development and treatmentNeutralizationVirologyAntibodyHuman immunodeficiency virus (HIV)Reporter geneBiologyMedicineImmunologyGene expressionGene

MeSH terms

HeLa CellsHumansNeutralization TestsPredictive Value of TestsQuality ControlTime FactorsTransfectionReproducibility of ResultsBiomarkersHIV AntibodiesHIV-1Observer VariationHIV InfectionsPractice Guidelines as TopicGuideline Adherence

Citations

570

FWCI

7.16

field-weighted impact

References

Percentile

98%

vs. same field & year

Citations per year

References

Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1

Journal of Virology · 1998 · 1,235 citations

Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy

Antimicrobial Agents and Chemotherapy · 2002 · 1,578 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.